Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Topiramate for abnormal eating behaviour in frontotemporal dementia.

Singam C, Walterfang M, Mocellin R, Evans A, Velakoulis D.

Behav Neurol. 2013 Jan 1;27(3):285-6. doi: 10.3233/BEN-120257.

2.

Managing abnormal eating behaviours in frontotemporal lobar degeneration patients with topiramate.

Shinagawa S, Tsuno N, Nakayama K.

Psychogeriatrics. 2013 Mar;13(1):58-61. doi: 10.1111/j.1479-8301.2012.00429.x.

3.

Impulse control disorders in frontotemporal dementia: spectrum of symptoms and response to treatment.

Pompanin S, Jelcic N, Cecchin D, Cagnin A.

Gen Hosp Psychiatry. 2014 Nov-Dec;36(6):760.e5-7. doi: 10.1016/j.genhosppsych.2014.06.005. Epub 2014 Jun 17.

PMID:
25042130
4.

Topiramate after adjustable gastric banding in patients with binge eating and difficulty losing weight.

Zilberstein B, Pajecki D, Garcia de Brito AC, Gallafrio ST, Eshkenazy R, Andrade CG.

Obes Surg. 2004 Jun-Jul;14(6):802-5.

PMID:
15318986
5.

Efficacy of topiramate in bulimia nervosa and binge-eating disorder: a systematic review.

Arbaizar B, Gómez-Acebo I, Llorca J.

Gen Hosp Psychiatry. 2008 Sep-Oct;30(5):471-5. doi: 10.1016/j.genhosppsych.2008.02.002. Epub 2008 Jul 23. Review.

PMID:
18774432
6.

Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 2: improvement in psychiatric measures.

Hedges DW, Reimherr FW, Hoopes SP, Rosenthal NR, Kamin M, Karim R, Capece JA.

J Clin Psychiatry. 2003 Dec;64(12):1449-54.

PMID:
14728106
7.

Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial.

McElroy SL, Arnold LM, Shapira NA, Keck PE Jr, Rosenthal NR, Karim MR, Kamin M, Hudson JI.

Am J Psychiatry. 2003 Feb;160(2):255-61. Erratum in: Am J Psychiatry. 2003 Mar;160(3):612.

PMID:
12562571
8.

Treatment of binge-eating disorder with topiramate: a clinical case series.

Shapira NA, Goldsmith TD, McElroy SL.

J Clin Psychiatry. 2000 May;61(5):368-72.

PMID:
10847312
9.

[The treatment of binge eating disorder - a review].

Papp I, Szumska I, Túry F.

Psychiatr Hung. 2015;30(3):268-77. Review. Hungarian.

PMID:
26471029
10.

Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 1: improvement in binge and purge measures.

Hoopes SP, Reimherr FW, Hedges DW, Rosenthal NR, Kamin M, Karim R, Capece JA, Karvois D.

J Clin Psychiatry. 2003 Nov;64(11):1335-41.

PMID:
14658948
11.

Pharmacological treatment of binge eating disorder: update review and synthesis.

Reas DL, Grilo CM.

Expert Opin Pharmacother. 2015;16(10):1463-78. doi: 10.1517/14656566.2015.1053465. Epub 2015 Jun 4. Review.

12.

Topiramate may modulate alcohol abuse but not other compulsive behaviors in frontotemporal dementia: case report.

Cruz M, Marinho V, Fontenelle LF, Engelhardt E, Laks J.

Cogn Behav Neurol. 2008 Jun;21(2):104-6. doi: 10.1097/WNN.0b013e31816bdf73.

PMID:
18541987
13.

Novel treatment options of binge eating disorder.

Marazziti D, Rossi L, Baroni S, Consoli G, Hollander E, Catena-Dell'Osso M.

Curr Med Chem. 2011;18(33):5159-64. Review.

PMID:
22050761
14.

Topiramate for binge-eating disorder.

Appolinario JC, Coutinho W, Fontenelle L.

Am J Psychiatry. 2001 Jun;158(6):967-8. No abstract available.

PMID:
11384917
15.

[Supervised off-label prescribing of topiramate for binge eating disorder within the system CAMTEA].

Guardia D, Rolland B, Deheul S, Danel T, Bordet R, Cottencin O.

Therapie. 2012 Sep-Oct;67(5):480-1. doi: 10.2515/therapie/2012063. Epub 2012 Dec 18. French. No abstract available.

PMID:
23241259
16.

Latest advancements in the pharmacological treatment of binge eating disorder.

Marazziti D, Corsi M, Baroni S, Consoli G, Catena-Dell'Osso M.

Eur Rev Med Pharmacol Sci. 2012 Dec;16(15):2102-7. Review.

17.

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders.

Aigner M, Treasure J, Kaye W, Kasper S; WFSBP Task Force On Eating Disorders..

World J Biol Psychiatry. 2011 Sep;12(6):400-43. doi: 10.3109/15622975.2011.602720. Review.

PMID:
21961502
18.

Combining Pharmacological and Psychological Treatments for Binge Eating Disorder: Current Status, Limitations, and Future Directions.

Grilo CM, Reas DL, Mitchell JE.

Curr Psychiatry Rep. 2016 Jun;18(6):55. doi: 10.1007/s11920-016-0696-z. Review. Erratum in: Curr Psychiatry Rep. 2016 Sep;18(9):84.

PMID:
27086316
19.

Current pharmacotherapy options for bulimia nervosa and binge eating disorder.

McElroy SL, Guerdjikova AI, Mori N, O'Melia AM.

Expert Opin Pharmacother. 2012 Oct;13(14):2015-26. doi: 10.1517/14656566.2012.721781. Epub 2012 Sep 4. Review.

PMID:
22946772
20.

Lamotrigine use in patients with binge eating and purging, significant affect dysregulation, and poor impulse control.

Trunko ME, Schwartz TA, Marzola E, Klein AS, Kaye WH.

Int J Eat Disord. 2014 Apr;47(3):329-34. doi: 10.1002/eat.22234. Epub 2013 Dec 16.

PMID:
24343841

Supplemental Content

Support Center